Continuing Lamivudine vs Switching to Entecavir in Patients With Detectable HBV DNA

Press/Media: Press / Media

Period	2018 Oct 2

Media coverage

Title	Continuing Lamivudine vs Switching to Entecavir in Patients With Detectable HBV DNA
Media name/outlet	Clinical Trials.gov
Country/Territory	United States
Date	18/10/2
Persons	SangHoon Ahn, YoungWan Kim, YoungKeun Kim, Junyong Park